These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3054276)

  • 21. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
    Schaefer RM; Leschke M; Strauer BE; Heidland A
    Am J Nephrol; 1988; 8(6):449-53. PubMed ID: 3218658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of erythropoietin on the dialysis prescription.
    Van Wyck DB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epoetin alfa in anaemic children or adolescents on regular dialysis.
    Bianchetti MG; Hämmerli I; Roduit C; Neuhaus TJ; Leumann EP; Oetliker OH
    Eur J Pediatr; 1991 May; 150(7):509-12. PubMed ID: 1915505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation.
    Nonnast-Daniel B; Creutzig A; Kühn K; Bahlmann J; Reimers E; Brunkhorst R; Caspary L; Koch KM
    Contrib Nephrol; 1988; 66():185-94. PubMed ID: 3292147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Disordered alpha 2-adrenoreceptor function in hemodialysis patients with renal anemia--a possible cause of increased blood pressure in relation to recombinant human erythropoietin?].
    Müller R; Steffen HM; Brunner R; Pollok M; Baldamus CA; Kaufmann W
    Klin Wochenschr; 1991 Oct; 69(16):742-8. PubMed ID: 1662322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Erythropoietin and arterial hypertension in patients with chronic renal insufficiency].
    Simon P
    Rev Med Interne; 1995; 16(6):457-61. PubMed ID: 7652230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.
    Koppensteiner R; Stockenhuber F; Jahn C; Balcke P; Minar E; Ehringer H
    BMJ; 1990 Jun; 300(6740):1626-7. PubMed ID: 2372642
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of recombinant human erythropoietin on hemodynamics in chronic hemodialysis patients].
    Tomura S
    Nihon Rinsho; 1991 Dec; 49 Suppl():695-701. PubMed ID: 1808338
    [No Abstract]   [Full Text] [Related]  

  • 29. Hemodynamic and volume changes by recombinant human erythropoietin (rHuEPO) in the treatment of anemic hemodialysis patients.
    Hori K; Onoyama K; Iseki K; Fujimi S; Fujishima M
    Clin Nephrol; 1990 Jun; 33(6):293-8. PubMed ID: 2376091
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in endocrinological functions in hemodialysis patients associated with improvements in anemia after recombinant human erythropoietin therapy.
    Akizawa T; Kinugasa E; Nakayama F; Takahashi T; Koshikawa S; Shimizu N
    Contrib Nephrol; 1990; 82():86-93. PubMed ID: 2093532
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of anemia in hemodialyzed children using recombinant human erythropoietin (Eprex). Results of a French multicenter clinical trial].
    Gagnadoux MF; Loirat C; Berthélémé JP; Maisin A; Kamoun A; Dabout D; Poisson D; Broyer M
    Nephrologie; 1994; 15(3):207-11. PubMed ID: 7969713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical studies of recombinant human erythropoietin in patients on long-term dialysis].
    Ji SM; Li LS; Ji DX
    Zhonghua Nei Ke Za Zhi; 1993 Feb; 32(2):100-2. PubMed ID: 8404323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemodynamic mechanism of the elevation in blood pressure following the improvement of anemia with recombinant human erythropoietin.
    Kamata K; Marumo F; Onoyama K
    Jpn Circ J; 1991 Jul; 55(7):649-56. PubMed ID: 1880896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors limiting the correction of anemia with recombinant human erythropoietin].
    Casati S
    Minerva Urol Nefrol; 1991; 43(3):121-3. PubMed ID: 1817332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of hypertension induced by erythropoietin in patients on hemodialysis.
    Yamakado M; Umezu M; Nagano M; Tagawa H
    Clin Invest Med; 1991 Dec; 14(6):623-9. PubMed ID: 1794212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin-associated hypertension: what role for blood viscosity changes?
    Canaud B; Donadieu P; Polito C; Rivory JP; Mathieu-Daudé JC; Peterlongo F; Mion C
    Nephron; 1989; 51(3):430-1. PubMed ID: 2918961
    [No Abstract]   [Full Text] [Related]  

  • 37. Peripheral hemodynamics, blood viscosity, and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin.
    Steffen HM; Brunner R; Müller R; Degenhardt S; Pollok M; Lang R; Baldamus CA
    Contrib Nephrol; 1989; 76():292-8. PubMed ID: 2582783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis.
    Casati S; Passerini P; Campise MR; Graziani G; Cesana B; Perisic M; Ponticelli C
    Br Med J (Clin Res Ed); 1987 Oct; 295(6605):1017-20. PubMed ID: 3120854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seizures in haemodialysis patients treated with recombinant human erythropoietin.
    Edmunds ME; Walls J; Tucker B; Baker LR; Tomson CR; Ward M; Cunningham J; Moore R; Winearls CG
    Nephrol Dial Transplant; 1989; 4(12):1065-9. PubMed ID: 2517327
    [TBL] [Abstract][Full Text] [Related]  

  • 40. rHuEpo before dialysis and in dialysed patients.
    López-Gómez JM; Jofre R; Moreno F; Verde E; Valderràbano F
    Nephrol Dial Transplant; 1995; 10 Suppl 6():31-5. PubMed ID: 8524491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.